In addition to the analysis of the expression levels in neoplastic tissues, Gal-3 was also investigated as a potential new oncologic scintigraphic as well as blood marker in many different types of tumors, including the thyroid [183,184,185], the prostate [186] and the ovarian cancer [187]. This evidence concerns the gene LGALS3 and ovarian cancer.